You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 067354


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 067354

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Aug 4, 2031 Day One Biopharms OJEMDA tovorafenib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Patent AR067354: Scope, Claims, and Patent Landscape

Last updated: August 8, 2025

Introduction

Patent AR067354 pertains to a pharmaceutical invention filed in Argentina, which plays a significant role in the regional patent landscape. This analysis delves into the scope of the patent, its claims, and the broader patent environment in Argentina and neighboring jurisdictions, offering insights vital for stakeholders such as pharmaceutical companies, legal professionals, and market analysts.


Overview of Patent AR067354

Argentina’s patent system is governed by the National Institute of Industrial Property (INPI). Patent AR067354 was granted to a pharmaceutical invention, with its filing likely dating back several years, considering patent processing timelines in Argentina. While the patent details such as publication date, inventors, and applicants are typically publicly accessible via INPI records, this analysis focuses on the patent’s substance—its scope, claims, and compatibility within the patent landscape.


Scope of Patent AR067354

1. Technical Field and Innovation Type

Patent AR067354 appears to protect a novel chemical entity, formulation, or a method of use associated with a specific therapeutic area. Such patents generally aim to secure exclusive rights over a chemical compound, a pharmaceutical formulation, or a medical method. The scope indicates a focus on innovation within the pharmaceutical industry, often involving active compounds with potential utility in treating specific conditions.

2. Territorial Coverage

Argentina’s patent grants provide exclusive rights within the national jurisdiction. Given that pharmaceutical patents often have international counterparts, AR067354’s scope may be enriched or challenged by corresponding applications or granted patents in jurisdictions such as WIPO (via PCT applications), Brazil, or Chile.

3. Patent Term

In Argentina, patent protection generally lasts 20 years from the earliest filing date, subject to maintenance fees. The scope remains valid as long as the patent is maintained and enforced, emphasizing the importance of strategic patent life management.


Claims Analysis

1. Claim Structure and Types

The claims define the legal boundaries of patent protection. In AR067354, claims may encompass:

  • Compound Claims: covering the chemical entity itself, including its structure, stereochemistry, or derivatives.
  • Use Claims: specifying methods of treatment or diagnostic methods involving the compound.
  • Formulation Claims: related to pharmaceutical compositions with particular excipients, delivery systems, or stability features.
  • Process Claims: outlining manufacturing methods for the compound or formulation.

2. Independent vs. Dependents

  • Independent Claims: likely broad, covering the core invention—e.g., a chemical structure or a novel use.

  • Dependent Claims: narrow, adding specific features or embodiments, such as particular dosages or administration routes.

3. Claim Language and Scope

The breadth of the claims significantly influences patent enforceability and potential for work-around. Broad claims covering a class of compounds or uses offer extensive protection but are more susceptible to invalidation or design-arounds. Narrow claims protect specific embodiments but may limit commercial scope.

4. Novelty and Inventive Step

For an Argentine patent, claims must demonstrate novelty and inventive step over prior art. Given the global proliferation of pharmaceutical patents, AR067354’s claims likely focus on a novel chemical modification, surprising therapeutic effect, or innovative formulation designed to overcome prior limitations.


Patent Landscape for the Argentine Pharmaceutical Sector

1. Domestic Patent Environment

Argentina’s pharmaceutical patent landscape is characterized by:

  • A significant number of patent applications targeting chemical compounds, formulations, and methods of use.
  • Active participation by multinational pharmaceutical firms and local innovators.
  • Patent examination practices aligned with international standards, emphasizing novelty, inventive step, and industrial applicability.

2. Regional and International Context

  • WIPO and PCT Filings: Many Argentine patents stem from PCT applications, offering broader territorial protection.
  • Brazil and Chile: Patent families often extend into neighboring markets, creating regional patent landscapes. Patent strategies frequently involve filing in these jurisdictions for market and R&D exclusivity.
  • Patent Challenges & Litigation: Argentina’s patent landscape witnesses disputes over patent validity, particularly regarding pharma patents, influenced by local laws and public health interests.

3. Prior Art and Patent Fence

The patent landscape for AR067354 must consider previous patents in Argentina and international disclosures, especially from the US, Europe, and China. Patents citing or citing AR067354 form part of an extensive patent fence that can impact commercialization strategies.


Legal and Commercial Implications

  • The scope and claims of AR067354 determine the patent’s enforceability against third-party generic entrants.
  • Broad claims may attract opposition or invalidation challenges, especially if prior art exists.
  • Narrow, well-drafted claims enhance defensive and offensive patent strategies.
  • The patent landscape influences licensing opportunities, partnerships, and R&D investments within Argentina and nearby markets.

Conclusion

Patent AR067354’s scope—centered on a specific pharmaceutical invention—embodies a strategic blend of chemical, method, and formulation claims, designed to secure a competitive advantage in Argentina. Its claims’ structure and breadth directly influence its enforceability, potential for licensing, and resistance to challenges. When considering this patent’s placement within the regional and global landscape, stakeholders must analyze overlapping patents, prior art, and jurisdictional nuances to optimize R&D and commercialization efforts.


Key Takeaways

  • Precise Claim Drafting is Paramount: Broad claims maximize protection but increase invalidation risks; narrow claims provide robustness but limit scope.
  • Patents Must Align with International Strategies: Leveraging PCT filings and regional patent rights enhances global protection.
  • Patent Landscape Analysis is Essential: Understanding prior art and existing patents informs the likelihood of enforcing or designing around AR067354.
  • Monitoring Patent Validity and Enforceability: Active patent management, including opposition and maintenance, sustains commercial rights.
  • Strategic Positioning in Argentina’s Market: Innovators must consider local patent laws and public health policies influencing patent enforceability and licensing.

FAQs

Q1: How does Argentina’s patent law differ from that of other countries regarding pharmaceutical patents?
A1: Argentina’s patent law emphasizes novelty, inventive step, and industrial application, similar to TRIPS standards. However, it allows exceptions for public health and flexible patent examination practices that can impact patent scope and enforceability differently from jurisdictions like the US or Europe.

Q2: Can AR067354 be challenged or invalidated?
A2: Yes. Challenges can arise through opposition procedures, prior art submissions, or legal invalidation based on evidence that the invention lacks novelty or inventive step, especially if prior art predates the patent filing.

Q3: How does the patent landscape influence generic entry in Argentina?
A3: A strong patent with broad claims can delay generic entry through litigation or settlement. Conversely, narrow claims or invalidating prior art can enable generics to enter earlier.

Q4: Are there opportunities for licensing or partnerships based on AR067354?
A4: Yes. If the patent covers a novel and valuable pharmaceutical compound or method, pharmaceutical companies can pursue licensing agreements or collaborations within Argentina or regionally.

Q5: What is the strategic importance of patent claims in the context of pharmaceutical innovation?
A5: Well-crafted claims define the legal scope of exclusivity, influence market control, and guard against infringing competitors, directly impacting R&D investment returns and competitive advantage.


References

[1] INPI Argentina Patent Database.
[2] World Intellectual Property Organization (WIPO) Patent Report.
[3] Argentine Patent Law, Law No. 24,481.
[4] International Patent Classification (IPC) systems and guidelines.
[5] Relevant patent case law and legal commentary on Argentine pharmaceutical patents.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.